Clinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type I

NCT06576388 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Type I Spinal Muscular Atrophy

Interventions

DRUG: EXG001-307 injection

Sponsor

Guangzhou Jiayin Biotech Ltd